🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalBrazil ANVISA GLP-1 approvals — September 2026 Page 2

Brazil ANVISA GLP-1 approvals — September 2026

amy_econ_NJ Thu, Aug 7, 2025 at 3:13 PM 6 replies 1,238 viewsPage 2 of 2
Dr.PeteFamMed
Senior Member
2,012
9,234
Jan 2024
Minneapolis, MN
Aug 7, 2025 at 8:45 PM#6
FDA_TrackerJim said:
My experience ordering cross-border ordering internationally: I've ordered from a Canadian pharmacy.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Import rules are jurisdiction-specific and this board keeps giving US-shaped answers to non-US questions. What is a personal-import allowance in one country is a controlled-import offence in another.

19 14hyun_seoul, jim_asheville, matt_MKE and 16 others
Reply Quote Save Share Report
lisa_labSD
Member
278
1,234
Oct 2024
San Diego, CA
Aug 7, 2025 at 10:55 PM#7

The figures, for anyone assembling their own picture. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

18 13maya_sedona, stefan_berlin, Dr.EM_Chicago and 15 others
Reply Quote Save Share Report
Dr.EndoEP
Member
267
1,234
Oct 2024
El Paso, TX
Aug 8, 2025 at 1:05 AM#8
Dr.PeteFamMed said:
Import rules are jurisdiction-specific and this board keeps giving US-shaped answers to non-US questions.

Coming at Dr.PeteFamMed’s question from a different direction. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

Last edited: Aug 8, 2025 at 3:05 AM
17 12FranDenver, Dr.BariatricHTX, LindaRN_retired and 14 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
JakeBK_lifts
Member
523
2,345
Jul 2024
Brooklyn, NY
Aug 8, 2025 at 3:15 AM#9

One thing that is still open after RegAffairsDC’s answer:

How would you tell the difference between that and the alternative explanation?

16 11kate.chem, DataDave, Dr.GutHealth and 13 others
Reply Quote Save Share Report
amy_econ_NJ
Member
567
2,567
May 2024
Princeton, NJ
Aug 8, 2025 at 1:39 PM#10

OP back with an update, since a thread like this is useless without one.

Reporting back for the archive rather than for the thread: I did the narrow version of what was suggested, gave it the full interval, and it settled. Posting it because threads without a follow-up are half a thread.

Last edited: Aug 8, 2025 at 4:39 PM
16 16NurseLeah_Nash, gary_naperville, sean_dublin and 13 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register